RPS6KB1 and neoplasm: Overexpression of PPP2R2C suppressed cancer cell proliferation by inhibiting the activity of S6K in the mTOR pathway, and further promoting the binding of PP2A-C with S6K, indicating PP2A as a potent tumor suppressor in human brain cancer [268].